Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayuki Nitta

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Journal of Neurosurgery|August 20, 2013
Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumorsYoshihiro Muragaki, Jiro Akimoto, Takashi Maruyama, et al.
Biomed Research International|April 26, 2018
Elevated TERT Expression in TERT-Wildtype Adult Diffuse Gliomas: Histological Evaluation with a Novel TERT-Specific AntibodyKenta Masui, Takashi Komori, Yukinari Kato, et al.
Cancer Research|April 9, 2009
K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cellsRyuichiro Nakai, Shin-ichi Iida, Takeshi Takahashi, et al.
Plos One|June 10, 2010
Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapyMasayuki Nitta, David Kozono, Richard Kennedy, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2015
Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expressionDavid Kozono, Jie Li, Masayuki Nitta, et al.
Oncotarget|June 11, 2015
Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibitionYing Shen, Jie Li, Masayuki Nitta, et al.
Journal of Neurosurgery|January 21, 2023
A multicenter, randomized, placebo-controlled phase IIb trial of an autologous formalin-fixed tumor vaccine for newly diagnosed glioblastomasYoshihiro Muragaki, Eiichi Ishikawa, Takashi Maruyama, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Journal of Neurosurgery|August 20, 2013
Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumorsYoshihiro Muragaki, Jiro Akimoto, Takashi Maruyama, et al.
Biomed Research International|April 26, 2018
Elevated TERT Expression in TERT-Wildtype Adult Diffuse Gliomas: Histological Evaluation with a Novel TERT-Specific AntibodyKenta Masui, Takashi Komori, Yukinari Kato, et al.
Cancer Research|April 9, 2009
K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cellsRyuichiro Nakai, Shin-ichi Iida, Takeshi Takahashi, et al.
Plos One|June 10, 2010
Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapyMasayuki Nitta, David Kozono, Richard Kennedy, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2015
Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expressionDavid Kozono, Jie Li, Masayuki Nitta, et al.
Oncotarget|June 11, 2015
Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibitionYing Shen, Jie Li, Masayuki Nitta, et al.
Journal of Neurosurgery|January 21, 2023
A multicenter, randomized, placebo-controlled phase IIb trial of an autologous formalin-fixed tumor vaccine for newly diagnosed glioblastomasYoshihiro Muragaki, Eiichi Ishikawa, Takashi Maruyama, et al.
Pageof 8